首页> 外国专利> Use of compounds derived from imidazo 4,5-d pyrimidine, imidazo 4,5-d pyridazine hydrochloride and pirrolo 3,2-d pyrimidine substituted OXO, dpp-4 Inhibitors, for the treatment of Metabolic Diseases in pediatric patients, such as type 2 diabetes.

Use of compounds derived from imidazo 4,5-d pyrimidine, imidazo 4,5-d pyridazine hydrochloride and pirrolo 3,2-d pyrimidine substituted OXO, dpp-4 Inhibitors, for the treatment of Metabolic Diseases in pediatric patients, such as type 2 diabetes.

机译:衍生自咪唑并[4,5-d]嘧啶,咪唑并[4,5-d]哒嗪盐酸盐和pirrolo [3,2-d]嘧啶取代的OXO,dpp-4抑制剂的化合物在治疗代谢性疾病中的用途小儿患者,如2型糖尿病。

摘要

Diazol - 1.3 (pyrimidine Compounds, pyrimidine and diazin pyrrole (- 1.2 - 1.3 - diazol conjugated oxo substitutedDpp-4 inhibitors and their use for the treatment of Metabolic Disease in Paediatric patients, such as Pediatric Type 2 diabetes.
机译:Diazol-1.3(嘧啶化合物,嘧啶和重氮吡咯(-1.2-1.3-diazol共轭的oxo取代的Dpp-4抑制剂)及其在小儿患者如2型小儿糖尿病患者中的代谢性疾病的治疗。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号